Table 3 ICS doses by formulation and age
From: The use of inhaled corticosteroids in pediatric asthma: update
Drug | Daily dose ug (age ≤ 5 years) | Daily dose ug (age 6–11 year) | Daily dose ug (age ≥ 12 years) | ||||
|---|---|---|---|---|---|---|---|
Lowa | Low | Medium | High | Low | Medium | High | |
Betamethasone Dipropionate (CFC) | - | 100–200 | >200–400 | >400 | 200–500 | >500–1000 | >1000 |
Betamethasone Dipropionate (HFA) | 100 | 50–100 | >100–200 | >200 | 100–200 | >200–400 | >400 |
Budesonide (pMDI + spacer) | 200 | - | - | - | - | - | - |
Budesonide (DPI) | - | 100–200 | >200–400 | >400 | 200–400 | >400–800 | >800 |
Ciclesonide | 160 | 80 | >80–160 | >160 | 80–160 | >160–320 | >320 |
Fluticasone propionate (DPI) | - | 100–200 | >200–400 | >400 | 100–250 | >250–500 | >500 |
Fluticasone propionate (HFA) | 100 | 100–200 | >200–500 | >500 | 100–250 | >250–500 | >500 |
Mometasone furoate | Not studied below 4 years | 110 | 220–<440 | ≥440 | 110–220 | >220–440 | >400 |
Triamcinolone acetonide | Not studied | 400–800 | >800–1200 | >1200 | 400–1000 | >1000–2000 | >2000 |